Risk of secondary cancers after CAR-T cell therapy low, acco

Risk of secondary cancers after CAR-T cell therapy low, according to large study

Risk of secondary cancers after CAR-T cell therapy low, according to large study
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Mark Hamilton , Takeshi Sugio , Troy Noordenbos , David Miklos , Cancer Genomics Program , Drug Administration , Stanford Health Care , Stanford Cancer Institute , Stanford Medicine , Ash Alizadeh , Moghadam Family Professor , New England Journal ,